Study in Subjects With Small Primary Choroidal Melanoma

Summary

The primary objective is to assess the safety, immunogenicity and efficacy of one of three dose levels and repeat dose regimens of Light-activated AU-011 and one or two laser applications for the treatment of subjects with primary choroidal melanoma.

Timeline

Start

2017-02-27

Primary completion

2021-01-26

Completion

2021-01-26

Drugs

Indications